New COVID-19 Data: A Case for Optimism? - a podcast by Clinical Care Options

In this podcast episode, Paul E. Sax, MD, and Renslow Sherer, MD, discuss the clinical significance of new data on the prevention and treatment of COVID-19, including:

• COVID-19 in immunocompromised hosts
• Prime-Boost Strategy for COVID-19 vaccination
• COVID-19 surge effects
• Monoclonal antibody therapy for prevention and treatment
• Remdesivir update
• Repurposed drug, fluvoxamine
• What does the future of the pandemic look like?

Presenters:

Paul E. Sax, MD
Clinical Director
HIV Program and Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Renslow Sherer, MD
Director
International HIV Training Center
Professor of Medicine
Section of Infectious Diseases and Global Health
Department of Medicine
University of Chicago
Chicago, Illinois

Link to full program, including downloadable slidesets:
https://bit.ly/3zVTwYW

Further episodes of CCO Infectious Disease Podcast

Further podcasts by Clinical Care Options

Website of Clinical Care Options